Back
Editas Medicine Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
49
EDIT
Editas Medicine
Last Price:
3.28
Seasonality Move:
21.39%
Buy
56
EYPT
EyePoint Pharmaceuticals
Last Price:
12.05
Seasonality Move:
16.23%
Sell
49
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $3.12. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $11.61. The Score for EYPT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $3.12
The current trend is relatively stagnant and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $11.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 45.93 | Sell |
Chaikin Money Flow: | 1568900 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.01 - 3.39) | Sell |
Bollinger Bands (100): | (3.3 - 4.98) | Sell |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.78 | Buy |
Relative Strength Index (14 RSI): | 61.26 | Buy |
Chaikin Money Flow: | 288172 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.64 - 11.44) | Buy |
Bollinger Bands (100): | (8.05 - 10.13) | Buy |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.05 | Buy |
20-day SMA: | 3.18 | Sell |
50-day SMA: | 3.44 | Sell |
200-day SMA: | 5.51 | Sell |
8-day EMA: | 3.05 | Buy |
20-day EMA: | 3.18 | Sell |
50-day EMA: | 3.51 | Sell |
200-day EMA: | 5.28 | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.47 | Buy |
20-day SMA: | 10.45 | Buy |
50-day SMA: | 9.29 | Buy |
200-day SMA: | 14.61 | Sell |
8-day EMA: | 11.42 | Buy |
20-day EMA: | 10.64 | Buy |
50-day EMA: | 9.83 | Buy |
200-day EMA: | 11.64 | Sell |
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.05 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.83 per share.
Editas Medicine Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |